| Reintegration Into the Workforce After Kidney Transplantation Based on Urbanization Status in Switzerland | Kidney international reports |  | | 2025 | 114 | 220 |
|
| Outcome of Patients Transplanted for C3 Glomerulopathy and Primary Immune Complex-Mediated Membranoproliferative Glomerulonephritis | Kidney international reports | | | 2025 | 57 | 469 |
|
| BK polyomavirus serotype-specific antibody responses in blood donors and kidney transplant recipients with and without new-onset BK polyomavirus-DNAemia : A Swiss Transplant Cohort Study | American journal of transplantation | | | 2024 | 58 | 117 |
|
| Epidemiology and outcomes of bone and joint infections in solid organ transplant recipients | American journal of transplantation | | | 2022 | 252 | 154 |
|
| Risk factors for candidemia: a prospective matched case-control study | Critical Care | | | 2020 | 392 | 270 |
|
| Effect of C-Reactive Protein-Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia: A Randomized Clinical Trial | JAMA (Journal of the American Medical Association) | | | 2020 | 432 | 921 |
|
| Infectiologie sur mesure - 1. Immunogénétique des maladies infectieuses : premiers pas | Revue médicale suisse |  | | 2019 | 306 | 4 |
|
| Genetic and clinic predictors of new onset diabetes mellitus after transplantation | The Pharmacogenomics Journal | | | 2019 | 377 | 0 |
|
| Identification of an endoglin variant associated with HCV-related liver fibrosis progression by next-generation sequencing | Frontiers in Genetics | | | 2019 | 354 | 164 |
|
| Genetic immune and inflammatory markers associated with diabetes in solid organ transplant recipients | American Journal of Transplantation | | | 2019 | 462 | 0 |
|
| Fluconazole non-susceptible breakthrough candidemia after prolonged low-dose prophylaxis: a prospective FUNGINOS study | Journal of Infection | | | 2018 | 415 | 497 |
|
| Pentraxin-3 polymorphisms and invasive mold infections in acute leukemia patients receiving intensive chemotherapy | Haematologica | | | 2018 | 260 | 270 |
|
| LILRB1 polymorphisms influence posttransplant HCMV susceptibility and ligand interactions | Journal of Clinical Investigation | | | 2018 | 490 | 268 |
|
| Catheter retention as a consequence rather than a cause of unfavorable outcome in candidemia | Intensive Care Medicine | | | 2017 | 509 | 0 |
|
| Human microRNA responses predict cytomegalovirus replication following solid organ transplantation | The Journal of infectious diseases | | | 2017 | 521 | 336 |
|
| CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantation | Pharmacogenomics journal | | | 2017 | 716 | 0 |
|
| A Systematic Review and Meta-Analysis of HCV Clearance | Liver international | | | 2017 | 615 | 1 |
|
| BRIP1 coding variants are associated with a high risk of hepatocellular carcinoma occurrence in patients with HCV- or HBV-related liver disease | Oncotarget | | | 2017 | 577 | 2 |
|
| PIRATE project: point-of-care, informatics-based randomised controlled trial for decreasing overuse of antibiotic therapy in Gram-negative bacteraemia | BMJ Open | | | 2017 | 581 | 259 |
|
| Weighted Genetic Risk Scores and Prediction of Weight Gain in Solid Organ Transplant Populations | PloS one | | | 2016 | 540 | 275 |
|
| Polymorphisms in the lectin pathway of complement activation influence the incidence of acute rejection and graft outcome after kidney transplantation | Kidney international | | | 2016 | 508 | 663 |
|
| A significant effect of the killer cell immunoglobulin-like receptor ligand human leucocyte antigen-C on fibrosis progression in chronic C hepatitis with or without liver transplantation | Liver international | | | 2016 | 574 | 1 |
|
| PTX3 Polymorphisms and Invasive Mold Infections After Solid Organ Transplant | Clinical infectious diseases | | | 2015 | 545 | 1 |
|
| Corrigendum: reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes | Nature communications | | | 2015 | 592 | 183 |
|
| Influence of IFNL3/4 Polymorphisms on the Incidence of Cytomegalovirus Infection After Solid-Organ Transplantation | The Journal of infectious diseases | | | 2015 | 739 | 0 |
|
| A frequent hypofunctional IRAK2 variant is associated with reduced spontaneous hepatitis C virus clearance | Hepatology | | | 2015 | 383 | 0 |
|
| IL1B and DEFB1 Polymorphisms Increase Susceptibility to Invasive Mold Infection After Solid-Organ Transplantation | The Journal of infectious diseases | | | 2015 | 692 | 2 |
|
| The novel ss469415590 variant predicts virological response to therapy in patients with chronic hepatitis C virus type 1 infection | Alimentary pharmacology & therapeutics | | | 2014 | 651 | 0 |
|
| Clinical significance of the CCR5delta32 allele in hepatitis C | PloS one | | | 2014 | 596 | 279 |
|
| The IFNL3/4 ΔG variant increases susceptibility to cytomegalovirus retinitis among HIV-infected patients | AIDS | | | 2014 | 581 | 0 |
|
| Novel Approach Identifies SNPs in SLC2A10 and KCNK9 with Evidence for Parent-of-Origin Effect on Body Mass Index | PLOS genetics | | | 2014 | 762 | 1,309 |
|
| Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes | Nature communications | | | 2014 | 689 | 1,270 |
|
| Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma development | PloS one | | | 2013 | 719 | 670 |
|
| Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma | Journal of hepatology | | | 2013 | 682 | 0 |
|
| IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction | The Journal of experimental medicine | | | 2013 | 585 | 0 |
|
| Impact of soluble CD26 on treatment outcome and hepatitis C virus-specific T cells in chronic hepatitis C virus genotype 1 infection | PloS one | | | 2013 | 651 | 241 |
|
| Intrahepatic mRNA levels of SOCS1 and SOCS3 are associated with cirrhosis but do not predict virological response to therapy in chronic hepatitis C | Liver international | | | 2013 | 678 | 0 |
|
| IL28B polymorphisms predict response to therapy among chronic hepatitis C patients with HCV genotype 4 | Journal of viral hepatitis | | | 2013 | 654 | 0 |
|
| IL28B polymorphisms do not predict response to therapy in chronic hepatitis C with HCV genotype 5 | Gut | | | 2012 | 603 | 0 |
|
| Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapy | Hepatology | | | 2012 | 655 | 0 |
|
| A genetic validation study reveals a role of vitamin D metabolism in the response to interferon-alfa-based therapy of chronic hepatitis C | PloS one | | | 2012 | 781 | 442 |
|
| IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes | Hepatology | | | 2012 | 674 | 0 |
|
| Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection | Gastroenterology | | | 2012 | 641 | 0 |
|
| The impact of fibrosis and steatosis on early viral kinetics in HCV genotype 1-infected patients treated with Peg-IFN-alfa-2a and ribavirin | Journal of viral hepatitis | | | 2012 | 642 | 0 |
|
| IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C | Journal of hepatology | | | 2011 | 622 | 0 |
|
| Viral genotype-specific role of PNPLA3, PPARG, MTTP, and IL28B in hepatitis C virus-associated steatosis | Journal of hepatology | | | 2011 | 621 | 1 |
|
| Role of hepatitis C virus genotype 3 in liver fibrosis progression--a systematic review and meta-analysis | Journal of viral hepatitis | | | 2011 | 582 | 0 |
|
| Response prediction in chronic hepatitis C by assessment of IP-10 and IL28B-related single nucleotide polymorphisms | PloS one | | | 2011 | 647 | 343 |
|
| IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional study | PLoS medicine | | | 2011 | 680 | 293 |
|
| Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study | Gastroenterology | | | 2010 | 907 | 0 |
|
| Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C | Journal of hepatology | | | 2009 | 665 | 0 |
|
